Back to Journals Therapeutics and Clinical Risk Management Volume 10 Safety and efficacy of acarbose in the treatment of diabetes in Chinese patients Received 21 April 2014 Accepted for publication 4 June 2014 Published 30 June 2014 Volume 2014:10 Pages 505511 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Ke He*, Jun-Cheng Shi*, Xiao-Ming Mao Department of Endocrinology, Nanjing First Hospital Affiliated to Nanjing Medical University, Nanjing, People's Republic of China *These authors contributed equally to this work Abstract: Acarbose is an -glucosidase inhibitor that is commonly used to control postprandial blood glucose
Research suggests it may stimulate collagen and elastin production, improve skin firmness, reduce fine lines, and support faster wound healing
So, grab your popcorn, put on your 3D glasses, and let's dive into the glitzy world of weight loss drugs
Epithalon is primarily recognized for its potential role in the modulation of telomerase activity, a key enzyme involved in the maintenance and elongation of telomeres